Viralym-A (ViraCyte)

N/A

Report date: 2025/04/23 20:01:04

Base Information

Drug NameViralym-A (ViraCyte)

Drug Alias NameAdV-specific T cells - ViraCyteViralym-AAdV-specific T cell therapy - ViraCyteHLA-matched AdV-specific T cells - ViraCyteAdenovirus-specific T cell therapy - ViraCyte +[6]

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity

TargetsNot applicable

Therapy Area/IndicationsAdenoviridae Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesViracyte Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKalaris Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsAdenoviridae Infections

Other Information

ATC CodeN/A